Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.
Also called NCT01490918
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 165 participants
- Registry
-
NCT01490918
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01490918. Randomized; triple masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2020-08-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Acarbose
- Intervention (Drug)
- Placebo acarbose
- Intervention (Drug)
- placebo metformin
- Lead sponsor
- The Catholic University of Korea
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct01490918- Content hash
ec5f1e18bea44e739579bf3c75a08c9285c0fcdcaa519fec5b8ebeef54e9054b